WO2024033280 - FUROPYRIDIN AND FUROPYRIMIDIN, INHIBITORS OF PI4K, FOR USE IN THE TREATMENT OF PARASITE INFECTION AND MALARIA
National phase entry is expected:
Publication Number
WO/2024/033280
Publication Date
15.02.2024
International Application No.
PCT/EP2023/071761
International Filing Date
07.08.2023
Title **
[English]
FUROPYRIDIN AND FUROPYRIMIDIN, INHIBITORS OF PI4K, FOR USE IN THE TREATMENT OF PARASITE INFECTION AND MALARIA
[French]
FUROPYRIDINE ET FUROPYRIMIDINE, INHIBITEURS DE PI4K, DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT D'UNE INFECTION PARASITAIRE ET DU PALUDISME
Applicants **
MERCK PATENT GMBH
Inventors
KULKARNI, Shashank
SPANGENBERG, Thomas
CABRERA, Diego Gonzales
KANDEPEDU, Nishanth
VON GELDERN, Thomas W.
BASARAB, Gregory
Priority Data
63/370,838
09.08.2022
US
63/480,808
20.01.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4244 | |
| EPO | Filing, Examination, Granting | 19793 | |
| Japan | Filing, Examination, Granting | 2401 | |
| South Korea | Filing, Examination, Granting | 2608 | |
| USA | Filing, Examination, Granting | 9540 |
Total:
38,586
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to novel compounds having valuable properties, in particular those which can be used for the preparation of medicaments as well as methods of their use and manufacture. Said compounds are particularly useful as PI4K inhibitors and for the treatment or prevention of PI4K-related disorders such as protozoan infections like malaria and virus infections.[French]
La présente invention concerne de nouveaux composés ayant des propriétés d'intérêt, en particulier ceux qui peuvent être utilisés pour la préparation de médicaments, ainsi que des procédés d'utilisation et de fabrication de ceux-ci. Lesdits composés sont particulièrement utiles en tant qu'inhibiteurs de PI4K et pour le traitement ou la prévention de troubles liés à PI4K tels que des infections protozoaires, notamment la malaria et des infections virales.